News items related to: Q&A
-
Supporting more people to challenge injustices: A day in the life of a treatment activist
What got you interested in treatment activism to start with? Someone in my family was struggling to access life-saving medicines....
-
FAQs for women of childbearing potential and dolutegravir: Key interim considerations
A forum on the risks of preconception dolutegravir exposure has pulled together frequently asked questions (FAQs) designed to help provide...
-
IP-Watch Q&A with Carlos Correa: The myth of IP incentives for all nations
Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property,...
-
IP-Watch Q&A with Othoman Mellouk: The myth behind health and trade agreements
Othoman Mellouk is the Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC), and campaign...
